{"id":1054,"date":"2026-04-08T10:14:10","date_gmt":"2026-04-08T01:14:10","guid":{"rendered":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/?p=1054"},"modified":"2026-04-08T10:14:11","modified_gmt":"2026-04-08T01:14:11","slug":"%e6%9c%ac%e7%a0%94%e7%a9%b6%e5%ae%a4%e3%81%ae%e7%a0%94%e7%a9%b6%e6%88%90%e6%9e%9c%e3%82%92%e5%9f%ba%e7%9b%a4%e3%81%a8%e3%81%99%e3%82%8b%e5%89%b5%e8%96%ac%e3%83%99%e3%83%b3%e3%83%81%e3%83%a3%e3%83%bcep","status":"publish","type":"post","link":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/?p=1054","title":{"rendered":"\u672c\u7814\u7a76\u5ba4\u306e\u7814\u7a76\u6210\u679c\u3092\u57fa\u76e4\u3068\u3059\u308b\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fcEpiFrontier Therapeutics\u304cAMED\u300c\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u5f37\u5316\u4e8b\u696d\u300d\u306b\u63a1\u629e"},"content":{"rendered":"\n

<\/p>\n\n\n\n

\u6771\u4eac\u85ac\u79d1\u5927\u5b66\u751f\u547d\u79d1\u5b66\u90e8\u7d30\u80de\u60c5\u5831\u79d1\u5b66\u7814\u7a76\u5ba4\u304a\u3088\u3073\u7406\u5316\u5b66\u7814\u7a76\u6240\u306e\u7814\u7a76\u6210\u679c\u3092\u57fa\u76e4\u3068\u3057\u3066\u8a2d\u7acb\u3055\u308c\u305f\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc EpiFrontier Therapeutics, Inc.\uff08\u7c73\u56fd\uff09 \u306e\u65e5\u672c\u6cd5\u4eba EpiFrontier Therapeutics\u5408\u540c\u4f1a\u793e \u304c\u3001\u56fd\u7acb\u7814\u7a76\u958b\u767a\u6cd5\u4eba\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\uff08AMED\uff09\u306e \u300c\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u5f37\u5316\u4e8b\u696d\u300d\u306b\u63a1\u629e\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n\n\n\n

EpiFrontier Therapeutics\u306f\u3001\u6771\u4eac\u5927\u5b66\u30a8\u30c3\u30b8\u30ad\u30e3\u30d4\u30bf\u30eb\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba\uff08UTEC\uff09\u306e\u652f\u63f4\u306e\u3082\u3068\u8a2d\u7acb\u3055\u308c\u305f\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc\u3067\u3042\u308a\u3001\u672c\u7814\u7a76\u5ba4\u304c\u7406\u5316\u5b66\u7814\u7a76\u6240\u3068\u5171\u540c\u3067\u7814\u7a76\u3092\u9032\u3081\u3066\u304d\u305f\u30d2\u30b9\u30c8\u30f3\u30e1\u30c1\u30eb\u5316\u9175\u7d20 G9a\u306b\u5bfe\u3059\u308b\u65b0\u898f\u963b\u5bb3\u5264 RK-701\uff08EPF-001\uff09\u306e\u958b\u767a\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002\u4eca\u56de\u306e\u63a1\u629e\u306b\u3088\u308a\u3001\u938c\u72b6\u8d64\u8840\u7403\u75c7\u306a\u3069\u306e\u03b2\u30b0\u30ed\u30d3\u30f3\u7570\u5e38\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f\u81e8\u5e8a\u958b\u767a\u306e\u52a0\u901f\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n

\u672c\u4ef6\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306f\u3001\u4ee5\u4e0b\u306e\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u7b49\u3092\u3054\u53c2\u7167\u304f\u3060\u3055\u3044\u3002<\/p>\n\n\n\n

\u95a2\u9023\u60c5\u5831<\/p>\n\n\n\n

\u6771\u4eac\u85ac\u79d1\u5927\u5b66\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9
https:\/\/www.toyaku.ac.jp\/lifescience\/newstopics\/2025\/0325_7245.html<\/a><\/p>\n\n\n\n

EpiFrontier Therapeutics, Inc. \u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9
https:\/\/epifrontiertx.com\/epifrontier-therapeutics-secures-up-to-32m-grant-from-the-japan-agency-for-medical-research-and-development-to-advance-novel-therapy-for-beta-globin-disorders\/<\/a><\/p>\n\n\n\n

PR TIMES\uff08\u65e5\u672c\u8a9e\u7248\uff09
https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000001.000180030.html<\/a><\/p>\n\n\n\n

\u65e5\u7d4c\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u8a18\u4e8b<\/p>\n\n\n\n

https:\/\/bio.nikkeibp.co.jp\/atcl\/news\/p1\/26\/03\/23\/14391\/?n_cid=nbpbto_mled_am<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

\u6771\u4eac\u85ac\u79d1\u5927\u5b66\u751f\u547d\u79d1\u5b66\u90e8\u7d30\u80de\u60c5\u5831\u79d1\u5b66\u7814\u7a76\u5ba4\u304a\u3088\u3073\u7406\u5316\u5b66\u7814\u7a76\u6240\u306e\u7814\u7a76\u6210\u679c\u3092\u57fa\u76e4\u3068\u3057\u3066\u8a2d\u7acb\u3055\u308c\u305f\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc EpiFrontier Therapeutics, Inc.\uff08\u7c73\u56fd\uff09 \u306e\u65e5\u672c\u6cd5\u4eba EpiFrontier […]<\/p>\n","protected":false},"author":1,"featured_media":281,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,4],"tags":[],"class_list":["post-1054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-16","category-new"],"_links":{"self":[{"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/posts\/1054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1054"}],"version-history":[{"count":1,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/posts\/1054\/revisions"}],"predecessor-version":[{"id":1055,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/posts\/1054\/revisions\/1055"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=\/wp\/v2\/media\/281"}],"wp:attachment":[{"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ls.toyaku.ac.jp\/~cellsig\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}